Table 1 Demographic data, smoking habits, current treatments and comorbidities of the studied population.
Cohort (n = 50) | Control (n = 20) | |
|---|---|---|
AGE (years) | ||
Median (IQR) | 54.5 (51.0–61.0) | 41 (31.0–54.0) |
Sex | ||
M, number (%) | 1 (2.0) | 1 (5.0) |
F, number (%) | 49 (98.0) | 19 (95.0) |
Smoker | ||
Yes, number (%) | 3 (6.0) | 5 (25.0) |
No, number (%) | 46 (92.0) | 15 (75.0) |
Fibromyalgia score | ||
Total fibromyalgia score, median (IQR) | 21 (18–24) | |
Widespread Pain Index score, median (IQR) | 13 (10–16) | |
Symptom Severity Score, median (IQR) | 9 (7–10) | |
Clinical characteristics | ||
History of Hashimoto’s thyroiditis, number (%) | 9 (18) | |
Laboratory characteristics | ||
ANA positivity*, number (%) | 11 (22) | |
ACPA positivity, number (%) | 0 (0) | |
RF positivity, number (%) | 1 (2) | |
ESR, mm/h, median (IQR) | 13 (5–21) | |
